BD declares $1.05 quarterly dividend, sets Sept 30 payment date

scanx
Reviewed by
Riya DScanX News Team
Key Highlights

BD (Becton, Dickinson and Company) declared a $1.05 quarterly dividend, payable September 30, 2026, to shareholders of record on September 9, 2026. The move keeps the annualized dividend rate steady at $4.20 per share.

powered bylight_fuzz_icon
46817638

*this image is generated using AI for illustrative purposes only.

The Board of Directors of BD (Becton, Dickinson and Company) has declared a quarterly dividend of $1.05 per common share, signaling continued commitment to shareholder returns. The dividend is payable on September 30, 2026, to holders of record as of September 9, 2026. This announcement ensures that eligible shareholders will receive their distribution on the specified date, maintaining the company's indicated annual dividend rate of $4.20 per share.

Dividend Details

The key dates and figures for this dividend distribution are outlined below:

Metric Detail
Quarterly Dividend $1.05 per share
Record Date September 9, 2026
Payment Date September 30, 2026
Annualized Rate $4.20 per share

Shareholders must hold BD common stock by the close of business on the record date to be eligible for the payment. The company did not disclose any changes to its broader capital allocation strategy alongside this routine quarterly declaration.

About BD

BD is a leading global medical technology company focused on advancing health through innovation in medical essentials, connected care, biopharma systems, and interventional solutions. With more than 60,000 employees worldwide, the company delivers billions of products annually aimed at optimizing clinical operations and improving patient care outcomes.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might BD's consistent dividend payout impact its ability to fund R&D initiatives in connected care and biopharma systems?

What does the maintenance of the $4.20 annualized dividend rate suggest about BD's confidence in its near-term cash flow generation?

Could this steady shareholder return strategy influence BD's valuation relative to peers who are prioritizing aggressive M&A activity?

like16
dislike

Evercore ISI maintains Outperform on Becton Dickinson

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Evercore ISI Group analyst Vijay Kumar maintained an Outperform rating on Becton Dickinson and lowered the price target to $180 from $190.

powered bylight_fuzz_icon
44908612

*this image is generated using AI for illustrative purposes only.

Evercore ISI Group analyst Vijay Kumar has maintained an Outperform rating for Becton Dickinson while adjusting the valuation target. The firm lowered the price target to $180 from the previous $190.

Rating and Price Target Details

The revision reflects an updated assessment of the company's stock potential. The following table summarizes the changes:

Metric Value
Rating Outperform
Previous Price Target $190
New Price Target $180

The analyst's stance remains positive despite the reduction in the target price.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors drove Evercore ISI to lower the price target despite maintaining an Outperform rating?

How might Becton Dickinson's upcoming earnings report influence the revised price target?

What are the potential market reactions to this adjustment in the short term?

like17
dislike

More News on Becton Dickinson & Co